PIM Incidence in Older Cardiovascular Patients During COVID-19 Pandemics — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

PIM Incidence in Older Cardiovascular Patients During COVID-19 Pandemics — Stella

Home/Potentially Inappropriate Medications/

View on ClinicalTrials.gov

Recruiting

Back to Potentially Inappropriate Medications trials

Trial locations(1 site)

Russia

Tomsk NRMC, Tomsk

Key details

Sponsor

Tomsk National Research Medical Center of the Russian Academy of Sciences

Enrollment target

~1,000 participants

Started

July 2022

Primary completion

August 2027

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.